Drug Information

Drug General Information
Drug ID
D0LB7J
Drug Name
Gdc-0449
Drug Type
Small molecular drug
Indication Primitive Neuroectodermal Tumour Medulloblastoma [ICD10:C71.6] Phase 2 [1572601]
Formula
C19H14Cl2N2O3S
PubChem Compound ID
24776445
Drug Resistance Mutation (DRM)
DRM DRM Info
References
Ref 1572601A phase II, multicenter, open-label, 3-cohort trial evaluating the efficacy and safety of vismodegib in operable basal cell carcinoma.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.